Prot# A4311025: A Rollover Study for Subjects on Capravirine Who Wish to Continue Treatment with Open-Label Capravirine after Completing Study A4311002

Project: Research project

Project Details

StatusFinished
Effective start/end date11/7/03 → 4/16/07

Funding

  • Pfizer Inc. (A4311025)